Share
The world now has a new Covid-19 vaccine in its arsenal, and at a fraction of the cost per dose.
Unlike the three vaccines approved in the U.S. – Pfizer and Moderna’s mRNA vaccines and Johnson & Johnson’s viral vector vaccine, which provide the body instructions on how to produce the spike protein – the new CORBEVAX vaccine delivers the spike protein to the body directly. Like those other approved COVID-19 mRNA vaccines, CORBEVAX also requires two doses.
But this vaccine can be produced at a much larger scale because appropriate manufacturing facilities are already available. Also key to global access is that CORBEVAX can be stored in a regular refrigerator. Therefore, it is possible to produce millions of doses rapidly and distribute them relatively easily.
Another major difference is that the CORBEVAX vaccine was developed with global vaccine access in mind. The goal was to make a low-cost, easy-to-produce-and-transport vaccine using a well-tested and safe method.
Read more from Civil Beat
RELATED TOPICS:
Fresno Man Sentenced to 29 Years for Sexually Assaulting Children and Dog
12 hours ago
Bulldogs’ Two-Position Standout Tommy Hopfe Signs With Rockies
12 hours ago
Former Bulldog QB Jake Haener: I Have a ‘Rare Form of Skin Cancer’
13 hours ago
The Many Names of GOP Vice Presidential Nominee JD Vance
13 hours ago
Companies Cut Prices to Boost Sales, Consumers Respond
14 hours ago
Warner Bros. Discovery Sues NBA for Not Accepting Its Matching Offer
15 hours ago
CA Has Seen Many New Towns, but This Big Project Is Stalled